Osmotic stress regulates the anticoagulant efficiency of dermatan sulfate

Matrix Biology

Volumn 23, Issue 6, 2004, Pages 363-370

  McGee, Maria P ^a   Wagner, William ^a   Li, Lynne ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Coagulation; Glycosaminoglycans; Osmotic stress

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A; CALCIUM; DERMATAN SULFATE; GLYCOSAMINOGLYCAN;

ANTICOAGULATION; ARTICLE; DEHYDRATION; HUMAN; MEASUREMENT; OSMOTIC STRESS; PRIORITY JOURNAL; REACTION ANALYSIS; TITRIMETRY; WATER TRANSPORT;

AMINO ACID MOTIFS; ANTICOAGULANTS; ANTITHROMBINS; DERMATAN SULFATE; DOSE-RESPONSE RELATIONSHIP, DRUG; FACTOR XA; GLYCOSAMINOGLYCANS; HEPARIN; HEPARITIN SULFATE; HUMANS; IONS; KINETICS; OSMOSIS; THERMODYNAMICS; TIME FACTORS; WATER;

EID: 7944239497     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matbio.2004.07.006     Document Type: Article

References (38)

1. D.H. Atha, and K.C. Ingham Mechanism of precipitation of proteins by polyethylene glycols. Analysis in terms of excluded volume J. Biol. Chem. 256 1981 12108 12117
2. K. Aukland, and G. Nicolaysen Interstitial fluid volume: local regulatory mechanisms Physiol. Rev. 61 1981 556 643
3. O.G. Berg, and P.H. von Hippel Diffusion-controlled macromolecular interactions Annu. Rev. Biophys. Chem. 14 1985 131 160
4. J.R. Couchman, and A. Woods Structure and biology of pericellular proleoglycans D.D. Roberts R.P. Mecham Cell Surface and Extracellular Glycoconjugates, Structure and Function 1993 Academic Press 33 81
5. P.A. Craig, S.T. Olson, and J.D. Shore Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. Characterization of assembly, product formation and heparin dissociation steps in the factor Xa reaction J. Biol. Chem. 264 1989 5452 5461
6. P. Douzou Osmotic regulation of gene action Proc. Natl. Acad. Sci. U. S. A. 91 1994 1657 1661
7. S.P. Evanko, E.W. Raines, R. Ross, L.I. Gold, and T.N. Wight Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta Am. J. Pathol. 152 1998 533 546
8. P.G.W. Gettins Serpin structure, mechanism, and function Chem. Rev. 102 2002 4751 4803
9. S. Glasstone, K. Laidler, and H. Eyrin The Theory of Rate Processes 1941 McGraw-Hill New York
10. A.C. Guyton A concept of negative interstitial pressure based on pressure in implanted perforated capsules Circ. Res. 1963 399 408
11. R.V. Iozzo Matrix proteoglycans: from molecular design to cellular function Annu. Rev. Biochem. 67 1998 609 652
12. R.V. Iozzo, and J.D. San Antonio Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena J. Clin. Invest. 108 2001 349 355
13. J.D. Johnson, and J.A. Huntington The influence of Hing33e region residue Glu-381 on antithrombin allostery and metastability J. Biol. Chem. 279 2004 4913 4921
14. R.E. Jordan, G.M. Oosta, W.T. Gardner, and R.D. Rosenberg The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin J. Biol. Chem. 255 1980 10081 10090
15. L. Kejellen, and V. Lindahl Proteoglycans: structures and interactions Ann. Rev. Biochem. 60 1991 443 475
16. F.D. Kolodgie, A.P. Burke, A. Farb, D.K. Weber, R. Kutys, T.N. Wight, and R. Virmani Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insight into plaque erosion Arterioscler. Thromb. Vasc. Biol. 22 2002 1642 1648
17. S. Kugas Pore size distribution analysis of gel substances by size exclusion chromatography J. Chromatogr. 206 1981 449 461
18. A.D. Lander Proteoglycans: master regulators of molecular encounter? Matrix Biol. 17 1998 465 472
19. J.A. Marcum, D.H. Atha, L.M.S. Fritze, P. Nawroth, D. Stern, and R.D. Rosenberg Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan J. Biol. Chem. 261 1986 7507 7517
20. M.P. McGee, and J. Liang Regulation of glycosaminoglycan function by osmotic potentials. Measurement of water transfer during antithrombin activation by heparin J. Biol. Chem. 276 2001 49275 49282
21. M.P. McGee, and H. Teushler Protein hydration during generation of coagulation factor Xa in aqueous phase and on phospholipid membranes J. Biol. Chem. 270 1995 15170 15174
22. M.P. McGee, and W.D. Wagner Chondroitin sulfate anticoagulant activity is linked to water transfer. Relevance to proteoglycan structure in atherosclerosis Arterioscler. Thromb. Vasc. Biol. 23 2003 1921 1927
23. M.P. McGee, H. Teushler, N. Parthasarathy, and W.D. Wagner Specific regulation of procoagulant activity on monocytes. Intrinsic pathway inhibition by chondroitin 4,6-disulfate J. Biol. Chem. 270 1995 26109 26115
24. F.A. Meyer, and A. Silberberg In vitro study of the influence of some factors important for any physicochemical characterization of loose connective tissue in the microcirculation Microvasc. Res. 8 1974 263
25. R.J. Olds, D.A. Lane, B.C.J. Mille, and P.G.W. Gettins Antithrombin: the principal inhibitor of thrombin Semin. Thromb. Hemost. 20 1994 353 372
26. S.T. Olson, I. Bjõrk, and J. Shore Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteases by antithrombin Methods Enzymol. 222 1993 525 559
27. V.A. Parsegian, R.P. Rand, and D.C. Rau Macromolecules and water: probing with osmotic stress Methods Enzymol. 256 1995 43 94
28. V.A. Parsegian, R.P. Rand, and D.C. Rau Osmotic stress, crowding, preferential hydration, and binding: a comparison of perspectives Proc. Natl. Acad. Sci. U. S. A. 97 2000 3987 3992
29. A.H. Plaas, L.A. West, S. Wong-Palms, and F.R. Nelson Glycosaminoglycan sulfation in human osteoarthritis. Disease-related alterations at the non-reducing termini of chondroitin and dermatan sulfate J. Biol. Chem. 273 1998 12642 12649
30. A.R. Rezaie Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by a template mechanism. Evidence that calcium alleviates Gla domain antagonism of heparin binding to factor Xa J. Biol. Chem. 273 1998 16824 16827
31. C. Robinson, and S.G. Sligar Hydrostatic and osmotic pressure as tools to study macromolecular recognition Methods Enzymol. 259 1995 395 425
32. M.F. Scully, V. Ellis, N. Seno, and V.V. Kakkar The anticoagulant properties of mast cell product, chondroitin sulfate E Biochem. Biophys. Res. Commun. 137 1986 15 22
33. R.A. Shirk, N. Parthasarathy, J.D. San Antonio, F.C. Church, and W.D. Wagner Altered dermatan sulfate structure and reduced heparin cofactor II-stimulating activity of biglycan and decorin from human atherosclerotic plaque J. Biol. Chem. 275 2000 18085 18092
34. E. Stratikos, and P.G. Gettins Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70 Å and full insertion of the reactive center loop into beta-sheet A Proc. Natl. Acad. Sci. U. S. A. 96 1999 4808 4813
35. V.J. Streusand, I. Bjõrk, P.G.W. Gettins, M. Petitou, and S.T. Olson Mechanism of acceleration of antithrombin-proteinase reactions by low affinity heparin. Role of the antithrombin binding pentasaccharide in heparin rate enhancement J. Biol. Chem. 270 1995 9043 9051
36. A.N. Teien, U. Abildgaard, and M. Hook The anticoagulant effect of heparan sulfate and dermatan sulfate Thromb. Res. 8 1975 859 867
37. T.N. Wight Vascular proteoglycans H.G. Garg P.J. Roughley C.A. Hales Lung Biology in Health and Disease 2003 Marcel Dekker
38. T.N. Wight, N.W. Lark, and M.G. Kinsella Blood vessel proteoglycans T.N. Wright R.P. Mechan Biology of Extracellular Matrix: A series J.3 Biology of Proteoglycans 1987 Academic Press